Skip to main content
Clinical Trials/NCT04715919
NCT04715919
Completed
Not Applicable

Long Term Outcomes in Patients With Coronavirus Disease-19 (COVID-19) on Pulmonary Functions, Exercise Capacity, Lung Structure and Quality of Life

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital1 site in 1 country70 target enrollmentJanuary 15, 2021
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Enrollment
70
Locations
1
Primary Endpoint
Structural Change in Lung
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The investigators hypothese that lung involvement due to COVID-19 may cause structural changes in the lung in the long term. In this study the effects of structural changes in the lung on pulmonary function tests, exercise capacity and quality of life will be examined.

Detailed Description

Coronavirus disease-19 (COVID-19) has a clinical spectrum ranging from asymptomatic cases to severe cases requiring intensive care hospitalization due to respiratory failure. The disease mostly infects the lower respiratory tract. Typical computed tomography findings of lung involvement are bilateral, peripherally located ground glass density and consolidations. There is a close relationship between tomography findings and clinical severity. It is not known whether there will be complete recovery in the lungs. Investigators will evaluate pulmonary structures with chest computed tomography, respiratory capacity with pulmonary function tests (PFTs), exercise capacity with six minutes walk test and quality of life with short form-36 (SF-36) im patients who survivors of COVID-19 at least 6 months after hospital discharge.

Registry
clinicaltrials.gov
Start Date
January 15, 2021
End Date
June 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Cenk Kirakli, M.D.

Professor Doctor

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who were ≥18 years
  • COVID-19 confirmed by Real-Time PCR
  • At least 6 months after discharge

Exclusion Criteria

  • Patients who were \< 18 years
  • Pregnancy
  • Become bedridden after discharge

Outcomes

Primary Outcomes

Structural Change in Lung

Time Frame: up to 6 months after discharge

Chest Computed Tomography

Secondary Outcomes

  • Short Form Health Survey Score (SF-16)(up to 6 months after discharge)
  • Carbon monoxide diffusion capacity (DLCO)(up to 6 months after discharge)
  • Exercise Capacity(up to 6 months after discharge)

Study Sites (1)

Loading locations...

Similar Trials